Pharmafile Logo

Webinar: Demand assessment – Reflecting real world choices

October 9, 2015 | Demand assessment, methodology 

How study design which reflects doctors’ real world choices can optimise results.

There is no “one size fits all” approach to conducting demand assessments.

The best studies utilise a methodology which is appropriate to the product in development, the market in which it will launch, and which gives the respondent the most realistic experience. 

In this webinar quantitative experts Duncan Munro and Will Tolley demonstrate, utilising knowledge and experience garnered from Research Partnership’s 18 years of conducting global quantitative research studies for pharma, how study design which reflects doctors’ real world choices can optimise results. 

Effective methodology
We discuss how to select the most appropriate approach in order to ensure an effective demand assessment methodology is achieved

Framing the question
We examine how best to frame a question in order to gain maximum insight and to make the task more realistic for respondents

Case study examples
Using real life case study examples, we demonstrate a number of key challenges and explore the ways in which researchers can overcome these issues in order to better reflect real world choices

Answer your demand assessment questions

To view the webinar please visit: 
http://www.researchpartnership.com/news/2015/09/webinar-demand-assessment-reflecting-real-world-choices/

This content was provided by Inizio

Company Details

 Latest Content from  Inizio 

5 takeaways from Reuters’ Pharma USA 2026 – and what they mean for you

Pharma USA is North America’s largest cross-functional pharma event and Inizio was there to offer insights on patient engagement, accelerated product launches, and Intelligent Commercialization™. Now we’re back in the...

Precision Medical Affairs in Action: Using AI and Analytics to Elevate Strategy, Engagement, and Impact

Discover how AI, analytics and real-world data are reshaping Medical Affairs.

How did multifaceted support from across Inizio help a biotech firm prepare for launch?

Discover how teams from across Inizio provided a range of integrated services to give a client's product the best chance of launch success.

Our key takeaways from ISMPP EU 2026 – Evolving with Purpose: Excellence in an Era of Efficiency

Explore Inizio Medical's key takeaway from ISMPP EU 2026, including AI governance, transparency, patient partnership and evolving impact measurement.

Intelligent field team engagement: Turning shared knowledge into deeper insights and better decisions.

At Age of AI 2026, Inizio Medical’s Phil Wakefield and Inizio Ignite’s Tim Luxford will explore how cross-functional collaboration and AI can unlock faster, more actionable insights across medical and...

AI in practice: 4 real-world use cases in health and life sciences

Artificial Intelligence (AI) is often discussed in broad terms, with promises of transformation at scale. In practice, however, its value is realized in far more specific ways – when it...

How will AI change field training?

Learn how a next-generation approach to field training – powered by GenAI and avatar simulations and enabled through Intelligent Commercialization™ – can transform field force effectiveness by delivering scalable, always-on,...

Inizio Ignite Sparks a New Era of Connected Advisory Solutions

Inizio, a leading global commercialization partner for pharma and life sciences, today unveiled Inizio Ignite, a reimagined, fully integrated advisory partner designed to accelerate pharma performance through strategy, insights, and innovation.

MM+M Podcast explores AI-powered audience intelligence with Inizio Evoke

The MM+M Podcast features a conversation with Jamie Avallone, Chief Data Officer at Inizio Evoke, and Iris Lin, Product Science Lead at Inizio Evoke, who share their perspectives on what...

Inizio Engage CEO Jim Sage featured in pharmaphorum’s “12 Questions” series

Discover Jim Sage’s insights on leadership, industry challenges, and the transformative impact of data, technology, and patient-centric innovation in his latest pharmaphorum “12 Questions” interview.